New treatments are on the horizon for ankylosing spondylitis and two other debilitating conditions that affect up to three per cent of the global population – thanks to a research and development deal involving University of Queensland research.

University of Queensland researchers have developed a world-first vaccine-style therapeutic approach to treat rheumatoid arthritis, a debilitating disease affecting more than 450,000 people in Australia.